Evidence map›Paper›PMID 35283643›Full record

ArticleCancer management and research2022

Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular Involvement.

Xianjin Zhou, Sha Tian, Xian Zhou, Huimin Shi, Yi Li, Jianjiang Xiao, Kun Chen, Bobin Chen, Gezhi Xu, Qingping Wang

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Multimodal imaging for diagnosis and follow-up of primary vitreoretinal lymphoma: A systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Pooled it
  2. Ocular Imaging in Intraocular Lymphoma: A Review.Clinical & experimental ophthalmology · 2026
    Review
  3. Intraocular Lymphoma: A Review.Journal of ophthalmic & vision research · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xianjin ZhouEye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, People's Republic of China.
Sha TianDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.ORCID 0000-0002-5336-7573
Xian ZhouDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Huimin ShiDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Yi LiDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Jianjiang XiaoDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Kun ChenDepartment of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Bobin ChenDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Gezhi XuEye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, People's Republic of China.
Qingping WangDepartment of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Fudan University · CNEye & ENT Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe the characteristic manifestations of vitreoretinal lymphoma (VRL) with optical coherence tomography (OCT) and monitor their outcomes after treatmEnt. Patients and Methods: Patients with primary central nervous system lymphoma (PCNSL) and intraocular involvement were assigned to the VRL group. OCT manifestations were analyzed and changes in abnormalities were recorded after intravitreal methotrexate injections. OCT manifestations of PCNSL patients without intraocular involvement were analyzed as well (non-VRL group). Results: There were 48 eyes with high-quality OCT records in the VRL group, of which 19 had abnormal manifestations. The most frequent abnormality was outer retina (OR) fuzzy borders (14 of 19, 73.7%). Other abnormalities included: focal subretinal deposits (8 of 19, 42.1%), hyperreflective subretinal dots (2 of 19, 10.5%), pigment epithelium detachment (PED) (5 of 19, 26.3%), preretinal deposits (5 of 19, 26.3%), epiretinal membrane (3 of 19, 15.8%), cystoid macular edema (3 of 19, 15.8%), subretinal fluid (3 of 19, 15.8%), outer retina atrophy (2 of 19, 10.5%), unilateral optic papilledema (2 of 19, 10.5%), retinal thickening (1 of 19, 5.3%), and subretinal fibrosis (1 of 19, 5.3%). Nine eyes with retinal abnormalities were receiving regular intravitreal methotrexate. The retinal structure of seven eyes (only outer retina involved) returned to almost normal on OCT images. The remaining two eyes (with severe retinal vasculitis) showed little improvement after treatment. Conclusion: OCT is helpful for the diagnosis of PCNSL with intraocular involvement and long-term follow-up of the disease. Summary Statement: The characteristic manifestations of vitreoretinal lymphoma (VRL) with optical coherence tomography (OCT) were described and their outcomes after treatment were monitored. These findings suggested that OCT is helpful for the diagnosis of PCNSL with intraocular involvement and long-term follow-up of the disease.

Indexed as

intravitreal injectionmethotrexateoptical coherence tomographyprimary central nervous system lymphomavitreoretinal lymphoma

Identifiers

PMID35283643
PMCPMC8906865
OpenAlexW4214859261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.